We Think Yifeng Pharmacy Chain (SHSE:603939) Can Stay On Top Of Its Debt
Jan 17
Have your own idea? Try our Stock Screener
Chinese (SSE) Drug Retail Industry Analysis
UpdatedFeb 01, 2025
DataAggregated Company Financials
Companies9
- 7D0.8%
- 3M-12.0%
- 1Y-27.6%
- YTDn/a
The Drug Retail industry has stayed flat over the last week. Unfortunately though, the industry is down 28% over the past 12 months. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Feb 2025 | CN¥80.6b | CN¥121.0b | CN¥3.9b | 18.6x | 20.7x | 0.7x |
| Mon, 30 Dec 2024 | CN¥88.3b | CN¥121.0b | CN¥3.9b | 20.4x | 22.6x | 0.7x |
| Wed, 27 Nov 2024 | CN¥86.5b | CN¥121.0b | CN¥3.9b | 19.3x | 22.2x | 0.7x |
| Fri, 25 Oct 2024 | CN¥84.5b | CN¥119.6b | CN¥4.3b | 19.5x | 19.5x | 0.7x |
| Sun, 22 Sep 2024 | CN¥69.2b | CN¥119.6b | CN¥4.3b | 15.7x | 16x | 0.6x |
| Tue, 20 Aug 2024 | CN¥71.1b | CN¥118.4b | CN¥4.8b | 15.9x | 14.8x | 0.6x |
| Thu, 18 Jul 2024 | CN¥78.2b | CN¥118.4b | CN¥4.8b | 18.7x | 16.3x | 0.7x |
| Sat, 15 Jun 2024 | CN¥101.0b | CN¥118.4b | CN¥4.8b | 23.9x | 21.1x | 0.9x |
| Mon, 13 May 2024 | CN¥127.0b | CN¥118.4b | CN¥4.8b | 26.7x | 26.5x | 1.1x |
| Wed, 10 Apr 2024 | CN¥118.3b | CN¥114.8b | CN¥5.2b | 21.8x | 22.6x | 1x |
| Fri, 08 Mar 2024 | CN¥111.6b | CN¥115.9b | CN¥5.8b | 19.2x | 19.2x | 1x |
| Sun, 04 Feb 2024 | CN¥111.5b | CN¥116.0b | CN¥5.7b | 19.6x | 19.4x | 1x |
| Tue, 02 Jan 2024 | CN¥128.1b | CN¥116.0b | CN¥5.7b | 22x | 22.3x | 1.1x |
| Thu, 30 Nov 2023 | CN¥128.8b | CN¥116.0b | CN¥5.7b | 22.7x | 22.5x | 1.1x |
| Sat, 28 Oct 2023 | CN¥115.4b | CN¥113.6b | CN¥5.7b | 22x | 20.3x | 1x |
| Mon, 25 Sep 2023 | CN¥120.7b | CN¥113.6b | CN¥5.7b | 23.4x | 21.3x | 1.1x |
| Wed, 23 Aug 2023 | CN¥125.9b | CN¥110.0b | CN¥5.5b | 27x | 23x | 1.1x |
| Fri, 21 Jul 2023 | CN¥125.9b | CN¥109.7b | CN¥5.4b | 26.6x | 23.1x | 1.1x |
| Sun, 18 Jun 2023 | CN¥135.1b | CN¥109.7b | CN¥5.4b | 28.6x | 24.8x | 1.2x |
| Tue, 16 May 2023 | CN¥132.8b | CN¥109.7b | CN¥5.4b | 27.3x | 24.4x | 1.2x |
| Thu, 13 Apr 2023 | CN¥148.7b | CN¥94.8b | CN¥4.4b | 40.1x | 34.1x | 1.6x |
| Sat, 11 Mar 2023 | CN¥138.7b | CN¥90.3b | CN¥4.0b | 34.5x | 34.5x | 1.5x |
| Mon, 06 Feb 2023 | CN¥138.9b | CN¥90.3b | CN¥4.0b | 34.7x | 34.5x | 1.5x |
| Wed, 04 Jan 2023 | CN¥155.5b | CN¥90.3b | CN¥4.0b | 39.9x | 38.6x | 1.7x |
| Fri, 02 Dec 2022 | CN¥159.3b | CN¥90.3b | CN¥4.0b | 40x | 39.6x | 1.8x |
| Sun, 30 Oct 2022 | CN¥128.3b | CN¥89.8b | CN¥4.0b | 32.9x | 32.1x | 1.4x |
| Tue, 27 Sep 2022 | CN¥106.1b | CN¥85.6b | CN¥3.8b | 33.3x | 27.8x | 1.2x |
| Thu, 25 Aug 2022 | CN¥114.5b | CN¥81.5b | CN¥3.7b | 36.4x | 30.9x | 1.4x |
| Sat, 23 Jul 2022 | CN¥121.0b | CN¥80.8b | CN¥3.7b | 38.7x | 32.5x | 1.5x |
| Mon, 20 Jun 2022 | CN¥107.0b | CN¥80.8b | CN¥3.7b | 34x | 28.7x | 1.3x |
| Wed, 18 May 2022 | CN¥97.9b | CN¥80.8b | CN¥3.7b | 30.5x | 26.3x | 1.2x |
| Fri, 15 Apr 2022 | CN¥94.4b | CN¥75.3b | CN¥4.1b | 25.9x | 23.3x | 1.3x |
| Sun, 13 Mar 2022 | CN¥116.0b | CN¥74.7b | CN¥4.1b | 32.5x | 28.4x | 1.6x |
| Tue, 08 Feb 2022 | CN¥121.3b | CN¥74.7b | CN¥4.1b | 35.1x | 29.7x | 1.6x |
Price to Earnings Ratio
29.7x
Current Industry PE
- Investors are pessimistic on the Chinese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 20.7x which is lower than its 3-year average PE of 25.7x.
- The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.67x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | -0.88% | |
| Consumer Staples | -0.10% | |
| Food and Staples Retail | -1.63% | |
| Drug Retail | 0.76% | |
| Big Box Super Stores | -0.79% | |
| Food Distributors | -0.97% | |
| Food Retail | -3.03% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603233 DaShenLin Pharmaceutical Group | CN¥14.15 | 2.0% +CN¥318.9m | -36.3% | PE19x | |
| 603939 Yifeng Pharmacy Chain | CN¥22.90 | 0.8% +CN¥230.4m | -29.3% | PE18.2x | |
| 002727 Yixintang Pharmaceutical Group | CN¥12.46 | 1.5% +CN¥111.3m | -29.5% | PE46.8x | |
| 605266 Jianzhijia Pharmaceutical Chain Group | CN¥22.18 | 1.6% +CN¥54.8m | -41.8% | PE14.7x | |
| 603883 LBX Pharmacy Chain | CN¥15.82 | 0.1% +CN¥15.2m | -23.7% | PE14.3x |
